The activation of the NLRP3 inflammasome in microglial cells drives neuroinflammation and dopaminergic neuronal damage in Parkinson’s disease. Inhibition of NLRP3 can alleviate disease progression and improve motor function. The gene discussed is NLRP3; the disease is Parkinson disease.